GeneDx (WGS) Short Interest Ratio & Short Volume $69.48 +1.22 (+1.79%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GeneDx Short Interest DataGeneDx (WGS) has a short interest of 2.08 million shares, representing 9.46% of the float (the number of shares available for trading by the public). This marks a -3.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 533,237 shares to cover all short positions.Current Short Interest2,080,000 sharesPrevious Short Interest2,150,000 sharesChange Vs. Previous Month-3.26%Dollar Volume Sold Short$159.87 millionShort Interest Ratio3.2 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares27,470,000 sharesFloat Size21,990,000 sharesShort Percent of Float9.46%Today's Trading Volume514,421 sharesAverage Trading Volume533,237 sharesToday's Volume Vs. Average96% Short Selling GeneDx? Sign up to receive the latest short interest report for GeneDx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWGS Short Interest Over TimeWGS Days to Cover Over TimeWGS Percentage of Float Shorted Over Time GeneDx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20242,080,000 shares $159.87 million -3.3%9.5%3.2 $76.86 12/15/20242,150,000 shares $162.17 million -5.7%9.8%3.5 $75.43 11/30/20242,280,000 shares $178.73 million -2.6%10.4%3.7 $78.39 11/15/20242,340,000 shares $160.13 million -10.0%10.7%4 $68.43 10/31/20242,600,000 shares $212.39 million +8.3%12.8%4.8 $81.69 10/15/20242,400,000 shares $143.98 million +8.6%12.6%5 $59.99 9/30/20242,210,000 shares $93.79 million -0.5%11.6%4.8 $42.44 9/15/20242,220,000 shares $84.07 million +1.4%11.6%5.1 $37.87 8/31/20242,190,000 shares $69.95 million +6.8%11.8%5.3 $31.94 8/15/20242,050,000 shares $67.42 million +7.9%11.1%4.9 $32.89 Get the Latest News and Ratings for WGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,900,000 shares $62.17 million +17.3%10.9%4.1 $32.72 7/15/20241,620,000 shares $55.89 million +32.8%9.8%2.9 $34.50 6/30/20241,220,000 shares $31.89 million +8.9%7.4%2.3 $26.14 6/15/20241,120,000 shares $32.23 million +6.7%6.8%2.5 $28.78 5/31/20241,050,000 shares $20.59 million -10.3%6.4%2.3 $19.61 5/15/20241,170,000 shares $24.76 million +0.9%7.2%2.7 $21.16 4/30/20241,160,000 shares $19.80 million +8.4%7.1%3 $17.07 4/15/20241,070,000 shares $10.57 million -2.7%6.6%5 $9.88 3/31/20241,100,000 shares $10.04 million +4.8%6.8%4.2 $9.13 3/15/20241,050,000 shares $12.61 million -4.6%6.5%3.8 $12.01 2/29/20241,100,000 shares $8.97 million -9.1%6.8%3.7 $8.15 2/15/20241,210,000 shares $5.38 million +14.2%7.5%3.1 $4.45 1/31/20241,060,000 shares $4.08 million +6.9%6.9%2.7 $3.85 1/15/2024991,900 shares $3.63 million +44.7%6.4%2.5 $3.66 12/31/2023685,700 shares $1.89 million +9.4%4.4%2 $2.75 12/15/2023626,600 shares $1.52 million -16.5%4.0%2 $2.43 11/30/2023750,100 shares $1.31 million +15.2%4.8%2.8 $1.75 11/15/2023651,400 shares $840,306.00 -16.4%4.2%2.9 $1.29 10/31/2023779,100 shares $1.45 million +1.7%5.0%8.5 $1.86 10/15/2023765,900 shares $2.47 million +8.7%4.9%10.2 $3.23 9/30/2023704,500 shares $2.56 million -2.7%4.5%9.6 $3.64 9/15/2023724,300 shares $3.17 million +2.6%4.7%7.8 $4.38 8/31/2023705,700 shares $3.14 million +1.4%4.2%5.4 $4.45 8/15/2023696,200 shares $3.57 million -2.3%4.2%4.3 $5.13 7/31/2023712,600 shares $5.28 million -0.8%4.3%4.1 $7.41 7/15/2023718,200 shares $4.83 million -6.9%4.3%3.9 $6.72 6/30/2023771,500 shares $4.60 million -18.7%4.6%4.4 $5.96 6/15/2023949,200 shares $6.95 million +18.8%5.7%5.8 $7.32 5/31/2023798,700 shares $6.01 million +7.8%4.9%5.1 $7.52 5/15/2023740,800 shares $5.32 million No Change4.6%5.6 $7.18Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now 12/15/20224,770,000 shares $1.34 million -25.2%2.8%2.8 $0.28 11/30/20226,380,000 shares $2.64 million -35.9%3.9%4.5 $0.41 11/15/20229,950,000 shares $8.76 million -8.1%6.0%9.6 $0.88 10/31/202210,830,000 shares $11.15 million -1.5%6.7%8.8 $1.03 10/15/202210,990,000 shares $9.42 million -4.0%6.8%8.8 $0.86 9/30/202211,450,000 shares $10.05 million +1.2%7.0%8.7 $0.88 9/15/202211,320,000 shares $11.32 million -5.0%7.0%6.3 $1.00 8/31/202211,920,000 shares $12.16 million -1.2%7.4%5.6 $1.02 8/15/202212,060,000 shares $28.94 million -19.8%7.5%5.3 $2.40 7/31/202215,030,000 shares $24.35 million +10.3%9.4%6.9 $1.62 7/15/202213,630,000 shares $21.54 million +9.9%8.5%5.8 $1.58 6/30/202212,400,000 shares $15.62 million +18.3%7.7%5.3 $1.26 6/15/202210,480,000 shares $15.20 million +11.4%6.5%4.6 $1.45 5/31/20229,410,000 shares $19.20 million +22.7%5.9%5.3 $2.04 5/15/20227,670,000 shares $15.72 million +61.8%4.8%4.8 $2.05 4/30/20224,740,000 shares $10.19 million -1.9%4.0%3.3 $2.15 4/15/20224,830,000 shares $12.61 million -1.0%4.1%3.4 $2.61 3/31/20224,880,000 shares $14.98 million +4.3%4.1%2.9 $3.07 3/15/20224,680,000 shares $12.36 million -6.0%4.0%2.7 $2.64 2/28/20224,980,000 shares $17.38 million +8.5%4.3%2.9 $3.49 2/15/20224,590,000 shares $16.98 million -14.8%3.9%2.6 $3.70 1/31/20225,390,000 shares $18.43 million -13.5%5.2%3 $3.42 1/15/20226,230,000 shares $25.17 million -20.9%5.6%3.8 $4.04 12/31/20217,880,000 shares $35.14 million +5.5%7.1%6.3 $4.46 12/15/20217,470,000 shares $36.30 million -4.2%6.7%5.7 $4.86 11/30/20217,800,000 shares $52.03 million -2.0%7.0%5.7 $6.67 11/15/20217,960,000 shares $62.25 million -7.4%7.2%5.9 $7.82 10/29/20218,600,000 shares $69.40 million +0.2%7.7%5.9 $8.07 10/15/20218,580,000 shares $66.84 million -11.9%7.7%5.7 $7.79 9/30/20219,740,000 shares $73.93 million -2.1%8.7%6.5 $7.59 9/15/20219,950,000 shares $88.46 million +24.8%8.9%7.7 $8.89 8/31/20217,970,000 shares $75.72 million +57.8%7.1%7.1 $9.50 8/13/20215,050,000 shares $57.97 million No Change4.5%5.1 $11.48 WGS Short Interest - Frequently Asked Questions What is GeneDx's current short interest? Short interest is the volume of GeneDx shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 2,080,000 shares of WGS short. 9.46% of GeneDx's shares are currently sold short. Learn More on GeneDx's current short interest. What is a good short interest ratio for GeneDx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WGS shares currently have a short interest ratio of 3.0. Learn More on GeneDx's short interest ratio. Which institutional investors are shorting GeneDx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GeneDx: Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for GeneDx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.46% of GeneDx's floating shares are currently sold short. Is GeneDx's short interest increasing or decreasing? GeneDx saw a drop in short interest in December. As of December 31st, there was short interest totaling 2,080,000 shares, a drop of 3.3% from the previous total of 2,150,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GeneDx's float size? GeneDx currently has issued a total of 27,470,000 shares. Some of GeneDx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GeneDx currently has a public float of 21,990,000 shares. How does GeneDx's short interest compare to its competitors? 9.46% of GeneDx's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to GeneDx: Hims & Hers Health, Inc. (29.37%), RadNet, Inc. (5.42%), Option Care Health, Inc. (2.26%), Guardant Health, Inc. (6.30%), Sotera Health (4.58%), Veracyte, Inc. (3.60%), BrightSpring Health Services, Inc. (16.20%), LifeStance Health Group, Inc. (8.88%), Surgery Partners, Inc. (14.89%), Privia Health Group, Inc. (5.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short GeneDx stock? Short selling WGS is an investing strategy that aims to generate trading profit from GeneDx as its price is falling. WGS shares are trading up $1.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GeneDx? A short squeeze for GeneDx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WGS, which in turn drives the price of the stock up even further. How often is GeneDx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WGS, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies HIMS Short Interest RDNT Short Interest OPCH Short Interest GH Short Interest SHC Short Interest VCYT Short Interest BTSG Short Interest LFST Short Interest SGRY Short Interest PRVA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WGS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.